Fundraising Fox

Clearflow

Irvine, US · Founded 2007 · Delaware corporation · 25 employees on LinkedIn · 3 known investors

ClearFlow develops PleuraFlow Active Clearance Technology, a device that maintains chest drain patency after cardiac surgery to reduce Retained Blood Syndrome complications, along with products for sternal fixation and reconstruction following sternotomy. The products are used in ICU and surgical settings for post-cardiac-surgery patient care.

HardwareHealthtechMedical Devices

Founders & leadership

Clearflow was founded in 2007 by Edward M. Boyle.

EM
Edward M. BoyleFounder
PM
Paul MolloyExecutive
HB
Hannah BeathardExecutive
AF
Andrew FirlikNamed on SEC filing
AD
Andrew D FirlikNamed on SEC filing
EM
Edward M Boyle, Jr.Named on SEC filing

Board

ASAlexander Suh
Alexander SuhinBoard directorManaging Director at California Technology Ventures
NSNed Scheetz
Ned ScheetzinBoard directorManaging Partner at Aphelion Capital
AD
Andrew D. FirlikBoard director
AS
Alex SuhBoard director
CM
Christopher MartinBoard director
EM
Edward M. Boyle, Jr.Board director

Investors · 3

Aphelion Capital
California Technology VenturesPasadena · $250K – $2M
Oregon Venture FundPortland · $500K – $5M

Reported raises · per SEC filings

Form D private placements

$49.4M disclosed across 9 rounds · 2011–2025

▶$2.1MraisedAug 2025 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul MolloyExecutive Officer, Director
  • Alexander SuhDirector
  • Edward M. BoyleDirector
  • Christopher MartinDirector
  • Hannah BeathardExecutive Officer
  • Ned ScheetzDirector
Offering amount
$4M
Amount sold
$2.1M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedJun 2024 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ned ScheetzDirector
  • Hannah BeathardExecutive Officer
  • Paul MolloyExecutive Officer, Director
  • Edward M. BoyleDirector
  • Alexander SuhDirector
  • Christopher MartinDirector
Offering amount
$3M
Amount sold
$2.3M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedAug 2020 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher MartinDirector
  • Paul MolloyExecutive Officer, Director
  • Alexander SuhDirector
  • Edward M. BoyleDirector
  • Ned ScheetzDirector
Offering amount
$7.5M
Amount sold
$7.5M
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedMay 2019 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander SuhDirector
  • Paul MolloyExecutive Officer, Director
  • Edward M. BoyleDirector
  • Ned ScheetzDirector
Offering amount
$12M
Amount sold
$7.6M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.5MraisedAug 2018 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul MolloyExecutive Officer, Director
Offering amount
$12.5M
Amount sold
$12.5M
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedAug 2015 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward M. Boyle, Jr.Director
  • Andrew D. FirlikDirector
  • Ned ScheetzDirector
  • Alexander suhDirector
  • Paul MolloyExecutive Officer, Director
Offering amount
$8.5M
Amount sold
$5.5M
Minimum investment
$2.8M
First sale
Jul 2015
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedNov 2014 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ned ScheetzDirector
  • Andrew D FirlikDirector
  • Edward M Boyle, Jr.Director
  • Paul MolloyExecutive Officer, Director
  • Alexander SuhDirector
Offering amount
$5M
Amount sold
$2.8M
Minimum investment
$240K
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedFeb 2014 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward M. Boyle, Jr.Director
  • Alexander SuhDirector
  • Ned ScheetzDirector
  • Andrew FirlikDirector
  • Molloy PaulExecutive Officer, Director
Offering amount
$4.2M
Amount sold
$4.2M
Minimum investment
$150K
First sale
Nov 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Medscape33 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Oup24 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.

Companies competing with Clearflow for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Clearflow has filed a notice of an exempt offering of securities to raise $3,000,000.00 in New Debt Financing. - intelligence360intelligence360.news · Jul 2024Clear Catheter Systems Raises $4 Million in VC Funding - Clearflowclearflow.com · Dec 2011Medical Device Start Up Clear Catheter Systems Raises $1.2 Million - Clearflowclearflow.com · Oct 2010

Frequently asked questions

What does Clearflow do?
ClearFlow develops PleuraFlow Active Clearance Technology, a device that maintains chest drain patency after cardiac surgery to reduce Retained Blood Syndrome complications, along with products for sternal fixation and reconstruction following sternotomy. The products are used in ICU and surgical settings for post-cardiac-surgery patient care.
Who founded Clearflow?
Clearflow was founded by Edward M. Boyle in 2007.
Who are Clearflow's investors?
Clearflow's investors include Aphelion Capital, California Technology Ventures, Oregon Venture Fund.
How much funding has Clearflow raised?
Clearflow has disclosed $49.4M raised across 9 rounds.
Where is Clearflow headquartered?
Clearflow is headquartered in Irvine, US.